Sign in
Home
About Us
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech News
Home
About Us
Contact Us
Home
Authors
Posts by Ngaiire
Ngaiire
435 POSTS
0 COMMENTS
Ngaiire Media
How do interactions between gut bacteria and fungi exacerbate crohn’s disease?
Ngaiire
-
July 25, 2019
Ngaiire Media
George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals
Ngaiire
-
July 23, 2019
Ngaiire Media
Researchers unveil experimental compound to block therapeutic target in blood cancer
Ngaiire
-
July 22, 2019
Ngaiire Media
Turning Shelved Drugs into a New Promise for Immuno-Oncology
Ngaiire
-
July 22, 2019
Ngaiire Media
Martian Gravity
Ngaiire
-
July 22, 2019
Ngaiire Media
Single-cell three-dimensional genome structures of rice gametes and unicellular zygotes
Ngaiire
-
July 22, 2019
Ngaiire Media
A QTL associated with leaf trichome traits has a major influence...
Ngaiire
-
July 21, 2019
Ngaiire Media
Scientists are trying to learn to use bacteria for mining in...
Ngaiire
-
July 19, 2019
Ngaiire Media
Take a bath 90 minutes before bedtime to get better sleep
Ngaiire
-
July 19, 2019
Ngaiire Media
Discovering how diabetes leads to vascular disease
Ngaiire
-
July 19, 2019
1
2
3
...
44
Page 1 of 44
Recent posts
How do interactions between gut bacteria and fungi exacerbate crohn’s disease?
Ngaiire
-
July 25, 2019
George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals
Ngaiire
-
July 23, 2019
Researchers unveil experimental compound to block therapeutic target in blood cancer
Ngaiire
-
July 22, 2019
Random article
How do interactions between gut bacteria and fungi exacerbate crohn’s disease?
George Mason University breast cancer treatment patent licensed by Targeted Pharmaceuticals
Researchers unveil experimental compound to block therapeutic target in blood cancer
Turning Shelved Drugs into a New Promise for Immuno-Oncology
